A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand
|
|
- Adelia Griselda Pearson
- 6 years ago
- Views:
Transcription
1 Journal of Antimicrobial Chemotherapy (2004) 54, DOI: /jac/dkh493 Advance Access publication 10 November 2004 A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand Brigitte Malbruny 1, Anja M. Werno 2, Trevor P. Anderson 2, David R. Murdoch 2,3 and Roland Leclercq 1 * JAC 1 Service de Microbiologie, CHU Côte de Nacre, Caen, France; 2 Microbiology Unit, Canterbury Health Laboratories, Christchurch; 3 Department of Pathology, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand Received 29 June 2004; returned 10 August 2004; revised 1 October 2004; accepted 5 October 2004 Objectives: To characterize a new type of resistance to clindamycin in Streptococcus agalactiae. Methods: Nineteen erythromycin-susceptible, clindamycin-resistant S. agalactiae isolates from New Zealand were studied. MICs of macrolide, lincosamide and streptogramin antibiotics were determined. Clindamycin and streptogramin resistance genes were searched for by PCR. Isolates were compared by serotyping and by DNA macrorestriction patterns determined by PFGE. Conjugative transfer of resistance traits to recipient strains of S. agalactiae and Enterococcus faecium was assayed. Results: The 19 S. agalactiae isolates were intermediate or resistant to clindamycin (MIC range: mg/l) and lincomycin (MIC range: 1 8 mg/l) and had high MICs of dalfopristin (4 32 mg/l), a streptogramin A-type antibiotic, compared with controls. By contrast, the strains were susceptible to macrolides and quinupristin, a streptogramin B-type antibiotic. This new phenotype was called LSA (lincosamide streptogramin A). Clindamycin resistance could not be transferred to recipient strains. Thirteen isolates belonged to serotype III and to a single PFGE genotype A, and five isolates belonged to serotype I and to genotype B. One isolate was non-typeable and belonged to a distinct genotype C. Conclusions: We have characterized a new LSA phenotype in S. agalactiae. Analysis of restriction patterns of S. agalactiae chromosomal DNA showed that the resistance was spread in a minimum of three bacterial clones. The genetic and biochemical basis for the resistance remains unknown. Keywords: streptococci, resistance mechanism, inhibition of protein synthesis, drug resistance, group B streptococcus Introduction Streptococcus agalactiae (group B streptococcus) is part of the commensal flora of the genital and digestive tracts. This bacterial species is also a common cause of severe infections in neonates and can cause various infections in adults, including bacteraemia and endocarditis. Penicillin G and ampicillin are the drugs of choice for prevention or treatment of S. agalactiae infections, whereas erythromycin or clindamycin are the recommended alternatives for patients who are intolerant to b-lactams. Whereas clinical isolates of S. agalactiae usually remain susceptible to penicillins, resistance to erythromycin has increased during the last decade in several countries. 1 5 The presence of mef(a) genes or of erm(b) or erm(tr) [subset of the erm(a) gene class] genes generally accounts for erythromycin resistance in clinical isolates. 3,4,6 The mef(a) gene confers resistance by drug efflux to 14- and 15-membered ring macrolides only, whereas the erm genes confer cross-resistance to erythromycin and clindamycin by ribosomal modification (macrolide lincosamide streptogramin B phenotype). Therefore, resistance to macrolides and related antibiotics in S. agalactiae usually presents as resistance to erythromycin alone or to both erythromycin and clindamycin. The observation that in New Zealand, among 117 S. agalactiae isolates, the most common resistance phenotype (11% of the strains) combined a low-level resistance to clindamycin (MIC range: 1 to 4 mg/l) with susceptibility to erythromycin (MIC < 0.25 mg/l) prompted us to study further this unusual type of resistance *Corresponding author. Tel: ; Fax: ; leclercq-r@chu-caen.fr JAC vol.54 no.6 q The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.
2 Clindamycin resistance in Streptococcus agalactiae Materials and methods Bacterial strains Nineteen S. agalactiae susceptible to erythromycin but resistant to clindamycin were obtained from vaginal swabs (n = 9), urine (n =2) and various other sites (n = 8). Eighteen were isolated from women (age: years) and one from a newborn. The isolates were identified by conventional methods and by latex agglutination assay (Murex Diagnostics, Dartford, UK). Serotyping of isolates was determined by using a latex agglutination assay (Bio-Rad, Marnesla-Coquette, France). Antibiotic susceptibility The MICs of ampicillin, clindamycin, dalfopristin, erythromycin, lincomycin, quinupristin, quinupristin dalfopristin and doxycycline were determined by the microbroth dilution method with Mueller Hinton broth (biomérieux) supplemented with 5% defibrinated sheep blood, as recommended by the NCCLS (tested range: mg/l). 8 All antibiotics were provided by their manufacturers. The plates were incubated overnight at 358C in ambient air. MICs of clindamycin were also determined by the Etest technique, as recommended by the manufacturer (AB Biodisk, Uppsala, Sweden). MICs were also determined in the presence and absence of 10 mg/l of reserpine (Sigma Chemicals, St Louis, MO, USA), as described previously. 9 An efflux mechanism could be suspected when there was at least a four-fold lower MIC in the presence of reserpine. A double disc-diffusion test with discs of erythromycin and clindamycin was used to test inducibility of resistance. 10 Blunting of the clindamycin zone of inhibition proximal to the erythromycin disc was taken to indicate an inducible type of resistance. Inactivation of antimicrobials Inactivation of clindamycin, lincomycin or dalfopristin was checked using a previously described technique. 11 Briefly, strains were streaked on brain heart infusion agar plates containing a heavy inoculum of Micrococcus luteus ATCC 9341 as an indicator organism, and 0.5 mg/l of dalfopristin or 0.2 mg/l of clindamycin, a concentration slightly higher than the MIC for M. luteus. Inactivation of the antibiotic in the culture medium would allow growth of the indicator in the surrounding medium. Staphylococcus aureus RN4220/pVMM26 inactivating lincomycin and clindamycin and S. aureus BM3002 inactivating dalfopristin were used as controls. 11,12 Molecular techniques PFGE was used to compare the isolates, as previously described. 13 Genomic DNA was isolated from an overnight-grown culture and the agarose-embedded DNA was digested with the enzyme SmaI (New England BioLabs Inc., Beverly, MA, USA). PFGE was performed using the CHEF-DR-III system (Bio-Rad). Gels were run at 6 V/cm, 148C, on a 1.2% agarose gel with pulse times of 5 35 s for 24 h. The bacteriophage l DNA ladder (New England BioLabs Inc.) was used as a size standard. The PFGE banding patterns were compared visually and interpretation of gels was performed using the criteria of Tenover et al. 14 Strains were considered genetically distinct if their restriction patterns differed by three or more bands. The lincomycin-resistant isolates were screened for lincosamide and streptogramin A-type resistance genes. The erm(a), erm(tr), erm(b) and erm(c) genes encoding ribosomal methylases and the lnu(a) and lnu(b) genes (previously called lina and linb) encoding lincosamide nucleotidyltransferases were detected by PCR amplification, as described previously. 12,15 The primers used to detect dalfopristin resistance genes were those described previously: vat(a), 16 vat(b), 17 vat(c), 18 vat(e), 19 vga(a), 20 vga(b) 21 and vga(av). 22 S. aureus strain BM3002 for vga(a) and vat(a), 11 BM3318 for vga(av), 22 HM290 for erm(a), HM1054R for erm(c), BM4611 for lnu(a ), 23 RN4220/pVMM26 for lnu(b), 12 Staphylococcus haemolyticus BM4610 for lnu(a), 23 E. faecium HM1032 for erm(b) and vat(d), and E. faecium UW 1965 for vat(e) 19 were used as controls. To detect mutations in the ribosomal target of lincosamides, we amplified a portion of the rrl gene for domain II from nt (Escherichia coli numbering), four fragments of domain V of 23S rrna (nt 1601 to 2900) and the entire rplv gene (for L22 ribosomal protein) using primers previously described for Streptococcus pyogenes and Streptococcus pneumoniae. 24,25 For amplification of the entire rpld gene (L4 ribosomal protein), primers 5 0 -ggtaacgtaccaggtgctaag (direct) and 5 0 -gatttcaacgcaaggcgacg (reverse), and primers 5 0 -ggtggtggtgttgtctttgg (direct) and 5 0 -gcacgtgtgtcaagttcaaatg (reverse) were used. The amplicons were analysed by single-strand conformation polymorphism (SSCP) analysis, as described previously. 25 Plasmids were extracted from streptococcal strains, as described previously by Ehrenfeld & Clewell. 26 Enterococcus faecalis JH2-2 containing plasmid pad1 was used as a control. 26 Filter mating Transfer of lincomycin and dalfopristin resistance from strains of S. agalactiae to the recipient strains of E. faecium HM1070 and S. agalactiae 132 (both susceptible to lincosamides and streptogramins A-type and resistant to rifampicin and fusidic acid) was attempted by filter mating, as previously described. 12 Transconjugants were selected on brain heart infusion containing rifampicin (20 mg/l), fusidic acid (10 mg/l) and lincomycin (2 mg/l) or dalfopristin (10 mg/l). Experiments were repeated independently three times. Results Characterization of clindamycin and dalfopristin resistant strains MICs of macrolide, lincosamide and streptogramin antibiotics for the 19 strains and for controls are shown in Table 1 and Figures 1 and 2. All strains were susceptible to ampicillin and resistant to doxycycline (not shown). Compared with susceptible controls, MICs of clindamycin, lincomycin and dalfopristin were increased by a two- to four-fold dilution factor. This shift in MICs of lincosamides and dalfopristin contrasted with maintained susceptibility to 14-, 15- and 16-membered macrolides, telithromycin and quinupristin. The synergism between quinupristin (a streptogramin B) and dalfopristin (a streptogramin A) was retained with no significant increase in MICs. The doubledisc diffusion test did not demonstrate inducible resistance to erythromycin. The MICs of lincosamides and dalfopristin were unchanged in the presence of the efflux pump inhibitor, reserpine. To the best of our knowledge, this phenotype is new in S. agalactiae and is called LSA (lincosamide streptogramin A). Thirteen LSA isolates belonged to serotype III, five to serotype I and one was non-typeable. The SmaI macrorestriction of genomic DNA generated about fragments of different sizes. Analysis of macrorestriction patterns led to the identification of three different genotypes. All serotype III isolates had DNA profiles that were indistinguishable (five isolates) or differing by 1041
3 B. Malbruny et al. Table 1. MICs of antibiotics for clinical isolates of S. agalactiae susceptible to macrolide, lincosamide and streptogramin antibiotics, with the LSA phenotype and for the susceptible control S. agalactiae 132 MIC range (mg/l) S. agalactiae (no. of strains) AMP ERY AZM SPI TEL LIN CLI CLI (Etest) QUI DAL Q/D Susceptible (10) ND S. agalactiae With LSA phenotype (19) AMP, ampicillin; AZM, azithromycin; CLI, clindamycin; DAL, dalfopristin; ERY, erythromycin; LIN, lincomycin; QUI, quinupristin; Q/D, quinupristin/dalfopristin; SPI, spiramycin; TEL, telithromycin; ND, not determined. Figure 1. Distribution of MICs of clindamycin for S. agalactiae isolates susceptible to clindamycin (white bars) and with the LSA phenotype (black bars). Figure 2. Distribution of MICs of dalfopristin for S. agalactiae isolates susceptible to dalfopristin (white bars) and with the LSA phenotype (black bars). Figure 3. PFGE patterns for some of the S. agalactiae isolates with the LSA phenotype. Total DNA from 13 S. agalactiae isolates (1 13) was digested with the SmaI restriction enzyme and submitted to PFGE. The characterized genotypes are indicated in parentheses. one or two bands (eight isolates) and were therefore clustered in a single genotype A (Figure 3). The five serotype I isolates formed a single genotypic cluster with indistinguishable profiles, whereas the non-typeable isolate displayed a distinct genotype C. Therefore, the spread of resistance appeared to be multiclonal. 1042
4 Clindamycin resistance in Streptococcus agalactiae Mechanism of clindamycin resistance To determine the resistance genotype of strains, we used primers specific for genes encoding resistance to lincosamides or to streptogramin A-type antibiotics in clinical isolates. Although these genes confer resistance to lincosamides or streptogramins A alone, and have not been previously reported to confer an LSA phenotype, a combination was possible. All PCR controls gave the expected results. However, no PCR product was obtained for the study isolates. Genes that encode ribosomal structures composing the target of lincosamides, rrl, rpld and rplv genes, from two strains with serotype I and III were analysed by PCR-SSCP. Compared with the sequences of S. agalactiae 2603 V/R and S. agalactiae NEM316 obtained from The Institute for Genomic Research website at and from The Institut Pasteur de Paris at recherche/unites/gmp/, respectively, 27,28 no mutation was found. Four strains of S. agalactiae of serotype I and III were tested for the transfer of clindamycin- or dalfopristin-resistance trait. No transfer to S. agalactiae 132 or to E. faecium HM1070 could be detected. No plasmid could be visualized after DNA extraction from the cells. Discussion S. agalactiae isolates intermediate or resistant to clindamycin but susceptible to erythromycin are already widespread in New Zealand. 7,29 Other reports from Taiwan show frequencies of clindamycin resistance greater than for erythromycin, suggesting that isolates similarly resistant may also be present in Asia. 1,2 In Canada, a single clindamycin-resistant and erythromycin-susceptible strain has been reported, which contained a lnu(b) [lin(b)] gene responsible for lincosamide nucleotidylation. 3 Although dalfopristin was not tested in the Canadian study, the lnu(b) gene has been shown in E. faecium to confer resistance to lincosamides only. 12 In contrast, the strains from New Zealand were co-resistant to lincosamide and streptogramin A-type antibiotics. The biochemical and genetic basis for this new LSA phenotype of resistance remains obscure. No known genes of resistance to lincosamide or streptogramin A-type antibiotics were found by PCR; no inactivation of antibiotics was detected by the microbiological screening test that we used and MICs of clindamycin and dalfopristin were unaffected by the pump inhibitor, reserpine. However, this latter result does not exclude an efflux mechanism. 30,31 The presence of the LSA phenotype in three S. agalactiae clones suggested a horizontal transfer of the resistance, although no plasmid could be visualized from the isolates and no conjugative transfer of resistance traits could be detected. The LSA phenotype of S. agalactiae is reminiscent of similar LSA phenotypes reported as intrinsic in E. faecalis 32,33 and acquired in S. aureus 34,35 In E. faecalis, the LSA intrinsic resistance is related to the expression of an Lsa protein that is similar to members of a superfamily of transport-related proteins known as ABC transporters capable of transporting molecules in response to ATP hydrolysis. 32,33 However, the efflux mechanism has not been proven. An outbreak with 27 isolates of methicillin-resistant S. aureus, displaying a similar LSA phenotype, has been reported in a French hospital. 34 However, the mechanism of resistance has not been further studied. Clindamycin resistance may be misidentified in strains with the LSA phenotype if only erythromycin is tested. This may be of clinical importance in countries where clindamycin is recommended as an ampicillin substitute for the treatment or prevention of S. agalactiae infections in case of allergy. The emergence of LSA resistance justifies the in vitro test of clindamycin, in particular in countries where this phenotype is prevalent. Acknowledgements We thank Patrick Trieu-Cuot for the gift of S. agalactiae 132, Wolfgang Witte for the gift of E. faecium UW 1965 and Nevine El Sohl for the gift of S. aureus BM3318. References 1. Wu, J.-J., Lin, K.-Y., Hsueh, P.-R. et al. (1997). High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrobial Agents and Chemotherapy 41, Ko, W. C., Lee, H. C., Wang, L. R. et al. (2001). Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan. European Journal of Clinical Microbiology and Infectious Diseases 20, de Azavedo, J. C., McGavin, M., Duncan, C. et al. (2001). Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B Streptococcus isolates from Ontario, Canada. Antimicrobial Agents and Chemotherapy 45, Betriu, C., Culebras, E., Gómez, M. et al. (2003). Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrobial Agents and Chemotherapy 47, Biedenbach, D. J., Stephen, J. M. & Jones, R. N. (2003). Antimicrobial susceptibility profile among b-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program- North America, Diagnostic Microbiology and Infectious Disease 46, Poyart, C., Jardy, L., Quesne, G. et al. (2003). Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrobial Agents and Chemotherapy 47, Werno, A. M., Anderson, T. P. & Murdoch, D. R. (2003). Antimicrobial susceptibilities of group B streptococci in New Zealand. Antimicrobial Agents and Chemotherapy 47, National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA. 9. Brenwald, N. P., Gill, M. J. & Wise, R. (1998). Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 42, Seppälä, H., Nissinen, A., Yu, Q. et al. (1993). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. Journal of Antimicrobial Chemotherapy 32, Bozdogan, B. & Leclercq, R. (1999). Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristindalfopristin against Enterococcus faecium. Antimicrobial Agents and Chemotherapy 43, Bozdogan, B., Berrezouga, L., Kuo, M. S. et al. (1999). A new resistance gene, linb, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrobial Agents and Chemotherapy 43, Gordillo, M. E., Singh, K. V., Baker, C. J. et al. (1993). Typing of group B streptococci: comparison of pulsed-field gel electrophoresis and conventional electrophoresis. Journal of Clinical Microbiology 31, Tenover, F. C., Arbeit, R. D., Goering, R. V. et al. (1995). Interpreting chromosomal DNA restriction patterns produced by 1043
5 B. Malbruny et al. pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, Angot, P., Vergnaud, M., Auzou, M. et al. (2000). Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. European Journal of Clinical Microbiology and Infectious Diseases 19, Allignet, J., Loncle, V., Simenel, C. et al. (1993). Sequence of a staphylococcal gene, vat, encoding an acetyltransferase inactivating the A-type compounds of virginiamycin-like antibiotics. Gene 130, Allignet, J. & El Solh, N. (1995). Diversity among the grampositive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatb. Antimicrobial Agents and Chemotherapy 39, Allignet, J., Liassine, N. & El Solh, N. (1998). Characterization of a staphylococcal plasmid related to pub110 and carrying two novel genes, vatc and vgbb, encoding resistance to streptogramins A and B and similar antibiotics. Antimicrobial Agents and Chemotherapy 42, Werner, G. & Witte, W. (1999). Characterization of a new enterococcal gene, satg, encoding a putative acetyltransferase conferring resistance to streptogramin A compounds. Antimicrobial Agents and Chemotherapy 43, Allignet, J., Loncle, V. & El Solh, N. (1992). Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginiamycin A-like antibiotics. Gene 117, Allignet, J. & El Solh, N. (1997). Characterization of a new staphylococcal gene, vgab, encoding a putative ABC transporter conferring resistance to streptogramin A and related compounds. Gene 202, Haroche, J., Allignet, J., Buchrieser, C. et al. (2000). Characterization of a variant of vga(a) conferring resistance to streptogramin A and related compounds. Antimicrobial Agents and Chemotherapy 44, Leclercq, R., Brisson-Noël, A., Duval, J. et al. (1987). Phenotypic expression and genetic heterogeneity of lincosamide inactivation in Staphylococcus spp. Antimicrobial Agents and Chemotherapy 31, Bingen, E., Leclercq, R., Fitoussi, F. et al. (2002). Emergence of group A streptococcus strains with different mechanisms of macrolide resistance. Antimicrobial Agents and Chemotherapy 46, Canu, A., Malbruny, B., Coquemont, M. et al. (2002). Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 46, Ehrenfeld, E. E. & Clewell, D. B. (1987). Transfer functions of the Streptococcus faecalis plasmid pad1: organization of plasmid DNA encoding response to sex pheromone. Journal of Bacteriology 169, Tettelin, H., Masignani, V., Cieslewicz, M. J. et al. (2002). Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proceedings of the National Academy of Sciences, USA 17, Glaser, P., Rusniok, C., Buchrieser, C. et al. (2002). Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Molecular Microbiology 45, Grimwood, K., Stone, P. R., Gosling, I. A. et al. (2002). Late antenatal carriage of group B Streptococcus by New Zealand women. Australian & New Zealand Journal of Obstetrics & Gynaecology 42, Jones, H. E., Brenwald, N. P., Owen, K. A. et al. (2003). A multidrug efflux phenotype mutant of Streptococcus pyogenes. Jounal of Antimicrobial Chemotherapy 51, Ahmed, M., Borsch, C. M., Neyfakh, A. A. et al. (1993). Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. Journal of Biological Chemistry 268, Singh, K. V., Weinstock, G. M. & Murray, B. E. (2002). An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrobial Agents and Chemotherapy 46, Dina, J., Malbruny, B. & Leclercq, R. (2003). Nonsense mutations in the lsa-like gene in Enterococcus faecalis isolates susceptible to lincosamides and streptogramins A. Antimicrobial Agents and Chemotherapy 47, Arpin, C., Lagrange, I., Gachie, J. P. et al. (1996). Epidemiological study of an outbreak of infection with Staphylococcus aureus resistant to lincosamides and streptogramin A in a French hospital. Journal of Medical Microbiology 44, Zarrouk, V., Bozdogan, B., Leclercq, R. et al. (2000). Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 44,
Int.J.Curr.Microbiol.App.Sci (2018) 7(8):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.378
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationMechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
More informationEUCAST Expert Rules for Staphylococcus spp IF resistant to isoxazolylpenicillins
EUAST Expert Rules for 2018 Organisms Agents tested Agents affected Rule aureus Oxacillin efoxitin (disk diffusion), detection of meca or mec gene or of PBP2a All β-lactams except those specifically licensed
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationDetection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital
ISSN: 2319-7706 Volume 3 Number 9 (2014) pp. 689-694 http://www.ijcmas.com Original Research Article Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a
More informationANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin
ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria
More informationWHY IS THIS IMPORTANT?
CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change
More informationMRSA surveillance 2014: Poultry
Vicky Jasson MRSA surveillance 2014: Poultry 1. Introduction In the framework of the FASFC surveillance, a surveillance of MRSA in poultry has been executed in order to determine the prevalence and diversity
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of Change in the approach to the administration of empiric antimicrobial therapy Increased
More informationAnnual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml)
Streptococcus pneumoniae Annual Report: 5 In 5, a total of, isolates of pneumococci were collected from 59 clinical microbiology laboratories across Canada. Of these, 733 (9.5%) were isolated from blood
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationConsequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationMID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance
Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationAntimicrobial Resistance Acquisition of Foreign DNA
Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple
More informationOrigins of Resistance and Resistance Transfer: Food-Producing Animals.
Origins of Resistance and Resistance Transfer: Food-Producing Animals. Chris Teale, AHVLA. Origins of Resistance. Mutation Brachyspira hyodysenteriae and macrolide and pleuromutilin resistance. Campylobacter
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationChristiane Gaudreau* and Huguette Gilbert
Journal of Antimicrobial Chemotherapy (1997) 39, 707 712 JAC Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter
More informationin a Tertiary Korean Hospital
Yonsei Med J 48(5):773-778, 2007 DOI 10.3349/ymj.2007.48.5.773 Macrolide Resistance Trends in in a Tertiary Korean Hospital β-hemolytic Streptococci Young Uh, 1,3 Gyu Yel Hwang, 1 In Ho Jang, 1 Hyun Mi
More informationSelective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016
Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that
More informationComparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria
Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development
More informationAntibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017
Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,
More informationMRSA ST398 from swine and cattle
Novel antimicrobial resistance genes among livestock-associated MRSA ST398 from swine and cattle Kristina Kadlec, Andrea Feßler and Stefan Schwarz Institute of Farm Animal Genetics,, Friedrich-Loeffler
More informationQuinupristin-dalfopristin Resistance in Gram-positive Bacteria: Experience from a Tertiary Care Referral Center in North India
Original Article 117 Quinupristin-dalfopristin Resistance in Gram-positive Bacteria: Experience from a Tertiary Care Referral Center in North India Antariksh Deep, M.D.*, Nidhi Goel, M.D.*, Rama Sikka,
More informationQ1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.
Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationBacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota
Bacterial Resistance of Respiratory Pathogens John C. Rotschafer, Pharm.D. University of Minnesota Antibiotic Misuse ~150 million courses of antibiotic prescribed by office based prescribers Estimated
More informationAntimicrobial Resistance: Do we know everything? Dr. Sid Thakur Assistant Professor Swine Health & Production CVM, NCSU
Antimicrobial Resistance: Do we know everything? Dr. Sid Thakur Assistant Professor Swine Health & Production CVM, NCSU Research Focus Antimicrobial Resistance On farm, Slaughter, Retail, Human Sample
More informationMethicillin-Resistant Staphylococcus aureus
Methicillin-Resistant Staphylococcus aureus By Karla Givens Means of Transmission and Usual Reservoirs Staphylococcus aureus is part of normal flora and can be found on the skin and in the noses of one
More informationPneumococci & streptococci Testing and clinical implications of susceptibility changes
Pneumococci & streptococci Testing and clinical implications of susceptibility changes Pierrette Melin Medical microbiology University Hospital of Liege,, Belgium pm-chu lg - May 2004 1 Key questions What
More informationMechanisms and Pathways of AMR in the environment
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
More informationnumber Done by Corrected by Doctor Dr Hamed Al-Zoubi
number 8 Done by Corrected by Doctor Dr Hamed Al-Zoubi 25 10/10/2017 Antibacterial therapy 2 د. حامد الزعبي Dr Hamed Al-Zoubi Antibacterial therapy Figure 2/ Antibiotics target Inhibition of microbial
More informationDetection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 7 (2017) pp. 4008-4014 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.607.415
More informationANTIMICROBIAL SUSCEPTIBILITY DETECTION OF ELEVATED MICs TO PENICILLINS IN β- HAEMOLYTIC STREPTOCOCCI
HAEMOLYTIC STREPTOCOCCI This specimen was designated as a sample from a skin wound that was to be cultured, identified to species level and susceptibility tested [1-3]. The culture contained a Streptococcus
More informationVariation in erythromycin and clindamycin resistance patterns between New Zealand and Australian group B streptococcus isolates
Australian and New Zealand Journal of Obstetrics and Gynaecology 2011 DOI: 10.1111/j.1479-828X.2011.01302.x Original Article Variation in erythromycin and clindamycin resistance patterns between New Zealand
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationA Norazah, M D*, V K E Lim, FRCPath**, MY Rohani, MPath*, A G M Kamel, MD**,
I ORIGINAL ARTICLE In-Vitro Activity of Quinupristin/ Dalfopristin, Levofloxacin and Moxifloxacin Against Fusidic Acid and Rifampicin-Resistant Strains of Methicillin Resistant Staphylococcus Aureus (MRSA)
More informationESCMID Online Lecture Library. by author
Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which
More informationOriginal Article Nepal Med Coll J 2013; 15(3): B Shrestha 1 and SS Rana 2
Original Article Nepal Med Coll J 2013; 15(3): 212-218 D test: A simple test with big implication for Staphylococcus aureus Macrolide-Lincosamide-Streptogramin B Resistance Pattern B Shrestha 1 and SS
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationagainst Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationMædica - a Journal of Clinical Medicine
MAEDICA a Journal of Clinical Medicine 2014; 9(2): 157-161 Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS High Incidence of Macrolide and Tetracycline Resistance among Streptococcus Agalactiae
More informationESCMID Online Lecture Library. by author
ESCMID Postgraduate Technical Workshop Antimicrobial susceptibility testing and surveillance of resistance in Gram-positive cocci: laboratory to clinic Current epidemiology of invasive enterococci in Europe
More informationExploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent
Supplementary materials Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent Shankar Thangamani 1, Haroon Mohammad 1, Mostafa Abushahba 1, Maha Hamed 1, Tiago Sobreira
More informationChallenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems
Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective
More informationJan A. Jacobs* and Ellen E. Stobberingh
Journal of Antimicrobial Chemotherapy (996) 37, 37-375 In-vitro antimicrobial susceptibility of the 'Streptococcus millerv group {Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius)
More information56 Clinical and Laboratory Standards Institute. All rights reserved.
Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationActivity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
Journal of Antimicrobial Chemotherapy Advance Access published July 31, 2010 J Antimicrob Chemother doi:10.1093/jac/dkq278 Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia
More informationGeoffrey Coombs 1, Graeme Nimmo 2, Julie Pearson 1, Samantha Cramer 1 and Keryn Christiansen 1
Community Onset MRSA Infections in Australia: A Tale of Two Clones Geoffrey Coombs 1, Graeme Nimmo 2, Julie Pearson 1, Samantha Cramer 1 and Keryn Christiansen 1 Community Associated MRSA First isolated
More informationAntimicrobials & Resistance
Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationActivities of the Centre for Zoonoses, Animal Bacterial Diseases and Antimicrobial Resistance (ZOBA) in Switzerland
Activities of the Centre for Zoonoses, Animal Bacterial Diseases and Antimicrobial Resistance (ZOBA) in Switzerland Gudrun Overesch Institute of Veterinary Bacteriology, Vetsuisse-Faculty, Bern 6 th EURL-AR
More informationJ. W. Mouton, H. P. Endtz, J. G. den Hollander, N. van den Braak and H. A. Verbrugh
Journal of Antimicrobial Chemotherapy (1997) 39, Suppl. A, 75 80 JAC In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with
More informationAntimicrobial Resistance Trends in the Province of British Columbia. August Epidemiology Services British Columbia Centre for Disease Control
Antimicrobial Resistance Trends in the Province of British Columbia August 2008 Epidemiology Services British Columbia Centre for Disease Control 5 Table of Contents Executive Summary...5 Objective...6
More informationAntibiotics & Resistance
What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed
More informationMonitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco
Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco licav@food.dtu.dk 1 DTU Food, Technical University of Denmark Outline EURL-AR
More informationSynergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci
Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious
More informationAntimicrobial agents. are chemicals active against microorganisms
Antimicrobial agents are chemicals active against microorganisms Antibacterial Agents Are chemicals active against bacteria Antimicrobials Antibacterial Antifungal Antiviral Antiparasitic: -anti protozoan
More informationand Health Sciences, Wayne State University and Detroit Receiving Hospital, Detroit, MI, USA
Journal of Antimicrobial Chemotherapy (2004) 54, Suppl. S1, i7 i15 DOI: 10.1093/jac/dkh313 JAC Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae
More informationResistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints
...PRESENTATIONS... Resistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints Angela B. Brueggemann, MS; and Gary V. Doern, PhD Presentation Summary Streptococcus pneumoniae
More informationSaxena Sonal*, Singh Trishla* and Dutta Renu* (Received for publication January 2012)
J. Commun. Dis. 44(2) 2012 : 97-102 Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus at a tertiary care hospital: Implications for clinical therapy
More informationInhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug
More informationAntimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana
Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana Beverly Egyir, PhD Noguchi Memorial Institute for Medical Research Bacteriology Department, University of Ghana Background
More informationAntibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
More informationBrief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot
More informationAn#bio#cs and challenges in the wake of superbugs
An#bio#cs and challenges in the wake of superbugs www.biochemj.org/bj/330/0581/bj3300581.htm ciss.blog.olemiss.edu Dr. Vassie Ware Bioscience in the 21 st Century November 14, 2014 Who said this and what
More informationFailure of Cloxacillin in a Patient with BORSA Endocarditis ACCEPTED
JCM Accepts, published online ahead of print on 30 December 2008 J. Clin. Microbiol. doi:10.1128/jcm.00571-08 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationIn vitro activity of telavancin against recent Gram-positive clinical isolates: results of the Prospective European Surveillance Initiative
Journal of Antimicrobial Chemotherapy (2008) 62, 116 121 doi:10.1093/jac/dkn124 Advance Access publication 19 April 2008 In vitro activity of telavancin against recent Gram-positive clinical isolates:
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationReceived 17 December 2003; accepted 22 December 2003
Journal of Antimicrobial Chemotherapy (2004) 53, 609 615 DOI: 10.1093/jac/dkh130 Advance Access publication 3 March 2004 In vitro post-antibiotic effect of fluoroquinolones, macrolides, β-lactams, tetracyclines,
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationβ-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018
β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa 12-14 March 2018 Antibiotic resistance center Institut Pasteur du Maroc Enterobacteriaceae (E. coli, Salmonella, ) S. aureus
More informationAntibiotic Resistance in Bacteria
Antibiotic Resistance in Bacteria Electron Micrograph of E. Coli Diseases Caused by Bacteria 1928 1 2 Fleming 3 discovers penicillin the first antibiotic. Some Clinically Important Antibiotics Antibiotic
More informationANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh
ANTIBIOTIC RESISTANCE Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development
More informationBrief Report THE DEVELOPMENT OF VANCOMYCIN RESISTANCE IN A PATIENT WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION
Brief Report THE DEVELOPMENT OF VANCOMYCIN RESISTANCE IN A PATIENT WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION KRZYSZTOF SIERADZKI, PH.D., RICHARD B. ROBERTS, M.D., STUART W. HABER, M.D.,
More informationORIGINAL ARTICLE /j x. University, Göteborg, Sweden
ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.01002.x Antibiotic resistance in Staphylococcus aureus colonising the intestines of Swedish infants E. Lindberg 1,2, I. Adlerberth 1 and A. E. Wold 1 1 Department
More informationEuropean Antimicrobial Resistance Surveillance System (EARSS) in Scotland: 2004
European Antimicrobial Resistance Surveillance System (EARSS) in Scotland: 2004 SECOND ANNUAL REPORT MJ Coyne 1, SJ Dancer 1, G Edwards 2, 3, D Morrison 2. 1 Health Protection Scotland, 2 Scottish MRSA
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationActivity of Linezolid Tested Against Uncommonly Isolated Gram-positive ACCEPTED
AAC Accepts, published online ahead of print on 8 January 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.01496-06 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationInterpretative reading of the antibiogram. Luis Martínez-Martínez Service of Microbiology University Hospital Marqués de Valdecilla Santander, Spain
Interpretative reading of the antibiogram Luis Martínez-Martínez Service of Microbiology University Hospital Marqués de Valdecilla Santander, Spain ANTIBIOGRAM RESISTANCE SUSCEPTIBILITY ANTIMICROBIAL AGENT
More informationAntibiotic resistance a mechanistic overview Neil Woodford
Antibiotic Resistance a Mechanistic verview BSc PhD FRCPath Consultant Clinical Scientist 1 Polymyxin Colistin Daptomycin Mechanisms of antibiotic action Quinolones Mupirocin Nitrofurans Nitroimidazoles
More informationWhat is multidrug resistance?
What is multidrug resistance? Umaer Naseer Senior Research Scientist Department of Zoonotic, Water- and Foodborne Infections Norwegian Institute of Public Health Magiorakos A.P. et al 2012 Definition of
More informationSurveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens
Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens Dr Pat Mitchell R & I Manager Production Stewardship APL CDC Conference, Melbourne June 2017 Dr Kylie Hewson
More informationMultidrug-Resistant Salmonella enterica in the Democratic Republic of the Congo (DRC)
Multidrug-Resistant Salmonella enterica in the Democratic Republic of the Congo (DRC) Octavie Lunguya 1, Veerle Lejon 2, Sophie Bertrand 3, Raymond Vanhoof 3, Jan Verhaegen 4, Anthony M. Smith 5, Benedikt
More informationPresence of extended spectrum β-lactamase producing Escherichia coli in
1 2 Presence of extended spectrum β-lactamase producing Escherichia coli in wild geese 3 4 5 A. Garmyn* 1, F. Haesebrouck 1, T. Hellebuyck 1, A. Smet 1, F. Pasmans 1, P. Butaye 2, A. Martel 1 6 7 8 9 10
More informationThe Search For Antibiotics BY: ASLEY, ELIANA, ISABELLA AND LUNISCHA BSC1005 LAB 4/18/2018
The Search For Antibiotics BY: ASLEY, ELIANA, ISABELLA AND LUNISCHA BSC1005 LAB 4/18/2018 The Need for New Antibiotics Antibiotic crisis An antibiotic is a chemical that kills bacteria. Since the 1980s,
More informationTERMS OF REFERENCE (June 1997, Reviewed 17/9/97) BACKGROUND. (opinion expressed on 05 February 1998)
Report of the Scientific Committee for Animal Nutrition on the Efficacy and Risk for Users of the Therapeutic Macrolides Antibiotics Tylosin and Spiramycin Used as Feed Additives (opinion expressed on
More informationStaphylococcus aureus Programme 2007 (SAP 2007) Hospital Survey MRSA Epidemiology and Typing Report
AGAR The Australian Group on Antimicrobial Resistance http://antimicrobial-resistance.com Staphylococcus aureus Programme 2007 (SAP 2007) Hospital Survey MRSA Epidemiology and Typing Report PREPARED BY:
More informationFinnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs
PathoProof TM Mastitis PCR Assay Mikko Koskinen, Ph.D. Director, Diagnostics, Finnzymes Oy Real time PCR based mastitis testing in milk monitoring programs PathoProof Mastitis PCR Assay Comparison of the
More informationAntimicrobial Resistance Strains
Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant
More informationDetermination of antibiotic sensitivities by the
Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More information